Iwasaki S, Araki H, Yamakawa T, Nishi K, Miyauchi Y
Department of Pharmacology, Kumamoto University Medical School, Japan.
Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:174-85.
The effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function were investigated in the isolated perfused rat heart. Occlusion of the left anterior descending coronary artery for 15 min and subsequent reperfusion provoked ventricular tachycardia in 9 out of 10 hearts and ventricular fibrillation in 7 out of 10. Aprindine or disopyramide was infused 15 min prior to the coronary occlusion in concentrations of 0.1 and 5.4 micrograms/ml, which were comparable to therapeutic free plasma concentrations in patients. Aprindine significantly decreased the incidence of ventricular tachycardia and fibrillation, compared with control (2/10, p less than 0.01 and 1/10, p less than 0.05, respectively). Disopyramide depressed only the occurrence of ventricular tachycardia (3/10, p less than 0.05). Neither of the drugs induced changes in heart rate, left ventricular systolic pressure, coronary flow or PR intervals, but they significantly improved the recovery of the left ventricular systolic pressure within 15 min after reperfusion, at which time most of the hearts had restored sinus rhythm. It is concluded that, at clinically effective concentrations, aprindine and disopyramide inhibit reperfusion-induced arrhythmias without deteriorating cardiac function in the isolated rat heart.
在离体灌注大鼠心脏中研究了阿普林定和丙吡胺对再灌注诱导的心律失常及心脏功能的影响。左冠状动脉前降支闭塞15分钟,随后再灌注,10个心脏中有9个出现室性心动过速,10个中有7个出现心室颤动。在冠状动脉闭塞前15分钟,以0.1和5.4微克/毫升的浓度输注阿普林定或丙吡胺,这与患者治疗时的游离血浆浓度相当。与对照组相比,阿普林定显著降低了室性心动过速和心室颤动的发生率(分别为2/10,p<0.01和1/10,p<0.05)。丙吡胺仅降低了室性心动过速的发生率(3/10,p<0.05)。两种药物均未引起心率、左心室收缩压、冠状动脉血流量或PR间期的改变,但它们显著改善了再灌注后15分钟内左心室收缩压的恢复情况,此时大多数心脏已恢复窦性心律。结论是,在临床有效浓度下,阿普林定和丙吡胺可抑制再灌注诱导的心律失常,且不损害离体大鼠心脏的心脏功能。